Management of hormonal therapy for the treatment of advanced hormone-dependent prostate cancer: A pharmacoeconomics assessment of the use of Degarelix – Firmagon® compared to generic triptorelin. ACTA MEDICA PERUANA, [S. l.], v. 28, n. 4, p. 188–193, 2024. Disponível em: https://amp.cmp.org.pe/index.php/AMP/article/view/1118. Acesso em: 25 dec. 2024.